CERTARA INC. - COMMON
10.99
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.08
+0.73%
Today's range
10.08 - 11.02
ISIN
N/A
Source
NASDAQ
-
Certara Reports Third Quarter 2022 Financial Results
07 Nov 2022 16:15:01 By Nasdaq GlobeNewswire
-
07 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
02 Nov 2022 17:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 Oct 2022 07:45:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
31 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara Announces Secondary Offering
11 Aug 2022 16:38:42 By Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2022 Financial Results
09 Aug 2022 16:15:01 By Nasdaq GlobeNewswire
-
Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
05 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
28 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara Appoints Rosemary Crane as New Independent Board Member
25 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
Certara Appoints Eran Broshy as New Independent Board Member
13 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
28 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
21 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2022 Financial Results
05 May 2022 16:15:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
03 May 2022 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 Mar 2022 16:15:00 By Nasdaq GlobeNewswire
-
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 Feb 2022 16:30:00 By Nasdaq GlobeNewswire